SearchClear
Mobile App

Google Play Apple Store
The Fibrotic Puzzle: Connecting Diagnosis, Progression, and Personalized Treatment in ILD
AMA/ABS/ANCC/ACPE - Live Symposium
Join internationally recognized ILD experts Steven D. Nathan, MD, Kevin R. Flaherty, MD, and Ayodeji Adegunsoye, MD, MS, as they explore the latest advances transforming the diagnosis and management of fibrotic interstitial lung diseases (ILDs).

This interactive symposium combines expert insights, real-world cases, and live audience polling to help clinicians diagnose ILD earlier, recognize disease progression, optimize antifibrotic therapy, and apply emerging evidence to personalize patient care. Leave with practical strategies you can implement immediately to improve outcomes for patients with fibrotic ILD.care.

Can't attend in-person? We have a virtual option available!
Attend the symposium, either live or virtually, and claim AMA/ABS/ANCC/ACPE credit after completion of the brief Post-Test Evaluation
Steven Nathan, MD, FCCP

Steven D. Nathan, MD, FCCP

Schar Chair
Medical Director, Advanced Lung Disease and Transplant Program
Inova Fairfax Hospital

Kevin Flaherty, MD

Kevin R. Flaherty, MD

Director, Interstitial Lung Disease Program
University of Michigan Health

Ayodeji Adegunsoye, MD, MSc, PhD, FCCP

Ayodeji Adegunsoye, MD, MSc, PhD, FCCP

Professor of Medicine
Scientific Director, Interstitial Lung Disease Program
University of Chicago Medicine

Live Symposium
Monday, October 19, 2026
6:00-7:30AM MST
The Fibrotic Puzzle: Connecting Diagnosis, Progression, and Personalized Treatment in ILD
AMA/ABS/ANCC/ACPE - Live Symposium
Steven Nathan, MD, FCCP

Steven D. Nathan, MD, FCCP

Schar Chair
Medical Director, Advanced Lung Disease and Transplant Program
Inova Fairfax Hospital

Kevin Flaherty, MD

Kevin R. Flaherty, MD

Director, Interstitial Lung Disease Program
University of Michigan Health

Ayodeji Adegunsoye, MD, MSc, PhD, FCCP

Ayodeji Adegunsoye, MD, MSc, PhD, FCCP

Professor of Medicine
Scientific Director, Interstitial Lung Disease Program
University of Chicago Medicine

Join internationally recognized ILD experts Steven D. Nathan, MD, Kevin R. Flaherty, MD, and Ayodeji Adegunsoye, MD, MS, as they explore the latest advances transforming the diagnosis and management of fibrotic interstitial lung diseases (ILDs).

This interactive symposium combines expert insights, real-world cases, and live audience polling to help clinicians diagnose ILD earlier, recognize disease progression, optimize antifibrotic therapy, and apply emerging evidence to personalize patient care. Leave with practical strategies you can implement immediately to improve outcomes for patients with fibrotic ILD.care.

Can't attend in-person? We have a virtual option available!
Attend the symposium, either live or virtually, and claim AMA/ABS/ANCC/ACPE credit after completion of the brief Post-Test Evaluation
Steven Nathan, MD, FCCP

Steven D. Nathan, MD, FCCP

Schar Chair
Medical Director, Advanced Lung Disease and Transplant Program
Inova Fairfax Hospital

Kevin Flaherty, MD

Kevin R. Flaherty, MD

Director, Interstitial Lung Disease Program
University of Michigan Health

Ayodeji Adegunsoye, MD, MSc, PhD, FCCP

Ayodeji Adegunsoye, MD, MSc, PhD, FCCP

Professor of Medicine
Scientific Director, Interstitial Lung Disease Program
University of Chicago Medicine


Live Symposium
Monday, October 19, 2026
6:00-7:30AM MST

 

Thank you for completing this activity!


An email will be sent to you shortly with your certificate attached. If you do not receive this email within 30 minutes, please check your "Junk" or "Spam" folder. You can also visit your profile page for a list of downloadable certificates you've earned.

For your convenience you can download your certificate by clicking the button below.


If you have any questions or experience issues, please contact us.

Overview

Join internationally recognized ILD experts Steven D. Nathan, MD, Kevin R. Flaherty, MD, and Ayodeji Adegunsoye, MD, MS, as they explore the latest advances transforming the diagnosis and management of fibrotic interstitial lung diseases (ILDs).

This interactive symposium combines expert insights, real-world cases, and live audience polling to help clinicians diagnose ILD earlier, recognize disease progression, optimize antifibrotic therapy, and apply emerging evidence to personalize patient care. Leave with practical strategies you can implement immediately to improve outcomes for patients with fibrotic ILD.care.

Can't attend in-person? We have a virtual option available!

The Fibrotic Puzzle: Connecting Diagnosis, Progression, and Personalized Treatment in ILD

AMA/ABS/ANCC/ACPE - Live Symposium

Steven Nathan, MD, FCCP

Steven D. Nathan, MD, FCCP

Schar Chair
Medical Director, Advanced Lung Disease and Transplant Program
Inova Fairfax Hospital

Kevin Flaherty, MD

Kevin R. Flaherty, MD

Director, Interstitial Lung Disease Program
University of Michigan Health

Ayodeji Adegunsoye, MD, MSc, PhD, FCCP

Ayodeji Adegunsoye, MD, MSc, PhD, FCCP

Professor of Medicine
Scientific Director, Interstitial Lung Disease Program
University of Chicago Medicine

Live Symposium
Monday, October 19, 2026
6:00-7:30AM MST
This symposium is not supported, endorsed, or accredited by the American College of Chest Physicians

20
Supported by independent educational grants from
Boehringer Ingelheim Pharmaceuticals, Inc. and United Therapeutics, a public benefit company




Multipage
8131
CHESTVideo.png
True
  • Pulmonology
Pulmonology
Change Settings